Invesco Ltd. - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 167 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.

Quarter-by-quarter ownership
Invesco Ltd. ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$100,518
-11.2%
93,072
+6.0%
0.00%
Q2 2023$113,257
+2.7%
87,796
+5.1%
0.00%
Q1 2023$110,277
-56.6%
83,543
-50.7%
0.00%
Q4 2022$254,248
-95.8%
169,498
-96.7%
0.00%
-100.0%
Q3 2022$6,099,000
+4.6%
5,168,413
+0.2%
0.00%0.0%
Q2 2022$5,830,000
-62.2%
5,159,866
-0.0%
0.00%
-50.0%
Q1 2022$15,435,000
+12.8%
5,161,717
-0.0%
0.00%
+33.3%
Q4 2021$13,680,000
-27.3%
5,162,199
-0.4%
0.00%
-40.0%
Q3 2021$18,807,000
-16.1%
5,180,947
+0.3%
0.01%
-16.7%
Q2 2021$22,415,000
+27.5%
5,164,760
+0.5%
0.01%
+20.0%
Q1 2021$17,582,000
-2.0%
5,140,933
+0.3%
0.01%0.0%
Q4 2020$17,943,000
+49.2%
5,126,593
+2.3%
0.01%
+25.0%
Q3 2020$12,029,000
+31.2%
5,012,235
+0.0%
0.00%
+33.3%
Q2 2020$9,171,000
+17.3%
5,011,761
+0.0%
0.00%0.0%
Q1 2020$7,818,000
-26.9%
5,011,696
+0.2%
0.00%0.0%
Q4 2019$10,700,000
+14.4%
5,000,1310.0%0.00%
+50.0%
Q3 2019$9,350,000
-28.4%
5,000,1310.0%0.00%
-33.3%
Q2 2019$13,050,000
+31729.3%
5,000,131
+42691.0%
0.00%
Q1 2018$41,0000.0%11,685
+10.0%
0.00%
Q4 2017$41,000
+41.4%
10,624
-8.4%
0.00%
Q3 2017$29,000
-3.3%
11,596
+4.3%
0.00%
Q2 2017$30,000
-63.0%
11,114
-69.5%
0.00%
Q2 2016$81,000
-28.9%
36,411
-33.5%
0.00%
Q1 2016$114,000
-59.6%
54,734
-41.1%
0.00%
Q4 2015$282,000
+25.3%
92,994
+1.8%
0.00%
Q3 2015$225,000
-21.9%
91,383
+1.9%
0.00%
Q2 2015$288,000
+50.0%
89,684
+67.0%
0.00%
Q1 2015$192,000
+34.3%
53,705
-14.8%
0.00%
Q4 2014$143,000
+23.3%
63,058
+5.4%
0.00%
Q3 2014$116,000
-43.7%
59,837
+5.7%
0.00%
Q2 2014$206,000
-7.2%
56,632
-0.9%
0.00%
Q1 2014$222,000
+303.6%
57,127
+194.0%
0.00%
Q4 2013$55,000
-14.1%
19,432
+8.0%
0.00%
Q3 2013$64,000
+18.5%
17,986
+11.4%
0.00%
Q2 2013$54,00016,1500.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders